牛牛AI助手已提取核心信息
On December 31, 2023, Armistice Capital, LLC and its managing member Steven Boyd filed a Schedule 13G with the United States Securities and Exchange Commission, disclosing a 6.71% ownership stake in Tonix Pharmaceuticals Holding Corp., amounting to 3,770,000 shares. The filing indicates that Armistice Capital, LLC, a Delaware-based investment adviser, and Steven Boyd, a U.S. citizen, share voting and dispositive power over these shares. The shares are held by the Master Fund, which is managed by Armistice Capital under an Investment Management Agreement. The Master Fund is an investment advisory client of Armistice Capital and is entitled to dividends or sale proceeds from the securities. The filing asserts that the shares were acquired in the ordinary course of business and not for the purpose of changing or influencing control of the issuer.
On December 31, 2023, Armistice Capital, LLC and its managing member Steven Boyd filed a Schedule 13G with the United States Securities and Exchange Commission, disclosing a 6.71% ownership stake in Tonix Pharmaceuticals Holding Corp., amounting to 3,770,000 shares. The filing indicates that Armistice Capital, LLC, a Delaware-based investment adviser, and Steven Boyd, a U.S. citizen, share voting and dispositive power over these shares. The shares are held by the Master Fund, which is managed by Armistice Capital under an Investment Management Agreement. The Master Fund is an investment advisory client of Armistice Capital and is entitled to dividends or sale proceeds from the securities. The filing asserts that the shares were acquired in the ordinary course of business and not for the purpose of changing or influencing control of the issuer.
2023年12月31日，停战资本有限责任公司及其管理成员史蒂芬·博伊德向美国证券交易委员会提交了附表13G，披露了Tonix Pharmicals Holding Corp. 6.71％的所有权，总额为3,77万股。该文件显示，驻特拉华州的投资顾问Armistice Capital, LLC和美国公民史蒂芬·博伊德共享对这些股票的投票权和处置权。这些股票由主基金持有，该基金由停战资本根据投资管理协议进行管理。万事达基金是停战资本的投资咨询客户，有权从证券中获得股息或出售收益。该文件称，这些股票是在正常业务过程中收购的，不是为了改变或影响发行人的控制权。
2023年12月31日，停战资本有限责任公司及其管理成员史蒂芬·博伊德向美国证券交易委员会提交了附表13G，披露了Tonix Pharmicals Holding Corp. 6.71％的所有权，总额为3,77万股。该文件显示，驻特拉华州的投资顾问Armistice Capital, LLC和美国公民史蒂芬·博伊德共享对这些股票的投票权和处置权。这些股票由主基金持有，该基金由停战资本根据投资管理协议进行管理。万事达基金是停战资本的投资咨询客户，有权从证券中获得股息或出售收益。该文件称，这些股票是在正常业务过程中收购的，不是为了改变或影响发行人的控制权。
有用
没用